Related Articles
HER-2/neu gene amplification by fluorescence in situ hybridization allows risk-group assessment in node-negative breast cancer.
Cyclooxygenase‑2 expression in non‑metastatic triple‑negative breast cancer patients
The course of serum HER-2/neu levels as an independent prognostic factor for survival in metastatic breast cancer
NAD(P)H:quinone oxidoreductase-1 overexpression predicts poor prognosis in small cell lung cancer
EGFR activity in HER-2 over-expressing metastatic breast cancer: evidence for simultaneous phosphorylation of Her-2/neu and EGFR